Advertisement

Zum Stand der Therapie der Pneumocystis carinii Pneumonie beim erworbenen Immunmangelsyndrom (Aids)

  • M. L’age
  • S. Skörde
  • K. Arasteh
  • W. Heise
  • P. Mostertz
  • K. Nehm
Conference paper

Zusammenfassung

Die Pneumocystis carinii Pneumonie (PcP) tritt bei 60–80% der Patienten mit Aids auf und ist mit 25% die häufigste Todesursache (Fauci 1985; Kovacs u. Mazur 1988; Update: Aquired immunodeficiency Syndrome 1986). Unabhängig von der Art der Therapie wird die Letalität der ersten PcP-Episoden in den meisten Studien zwischen 5% und 30% angegeben (PcP-Therapy Project Group 1984; Murray et al. 1984; Wofsy 1987).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Allegra CJ, Chabner BA, Tuazon CU et al. (1987) Trimetraxate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 317: 978–985PubMedCrossRefGoogle Scholar
  2. Brenner M, Ognibene FP, Lack EE et al. (1987) Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis 136:1199–1120PubMedCrossRefGoogle Scholar
  3. Fauci AS (1985) The acquired immunodeficiency syndrome, an update. Ann Intern Med 102: 800PubMedGoogle Scholar
  4. Holzman RS, Murren J, Torres R, Crocco J (1988) Outcomes of treatment of Pneumocystis carinii pneumonia: The role of oral cotrimoxazole. (4th International Congress on Aids, Stockholm, abstr)Google Scholar
  5. Kovacs JA, Mazur H (1988) Pneumocystis carinii pneumonia: therapy and prophylaxis. J Infect Dis 158: 254–259PubMedCrossRefGoogle Scholar
  6. MacFadden DK, Hyland RH, Inouye T, Edelson JD, Rodriguez CH, Rebuck AS (1987) Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet I: 1477–1479CrossRefGoogle Scholar
  7. McLees BD, Barlow JLR, Kuzma RJ, Barington DC, Schlechter PJ, Soerdsma A (1987) Studies on successful efflornithine treatment of Pneumocystis carinii pneumonia in Aids patients failing conventional therapy. 3rd International Congress on Aids, Washington, abstr)Google Scholar
  8. Medina I, Leoung G, Mills J, Hopewell P, Feigel D, Wofsy C (1987) Oral therapy for Pneumocystis carinii pneumonia (PcP) in Aids. A randomized double blind trial of trimethoprim- sulfamethoxazole versus dapsone trimethoprim for first episode of Pneumocystis carinii pneumonia in Aids. (3rd International Congress on Aids, Washington, abstr)Google Scholar
  9. Mottin D, Denis M, Dombret H, Rossert J, Mayqud CH, Akoun G (1987) Role for steroids in treatment of Pneumocystis carinii pneumonia in Aids. Lancet II: 519CrossRefGoogle Scholar
  10. Murray JF, Felton CP, Garay SM, Gottlieb MS, Hopewell PC, Stover DE, Tierstein AS (1984) Pulmonary complications of the acquired immunodeficiency syndrome: report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med 310: 1682–1688PubMedCrossRefGoogle Scholar
  11. PCP Therapy Project Group Haverkos HW (1984) Assessment of therapy for Pneumocystis carinii pneumonia. Am J Med 76: 501–508CrossRefGoogle Scholar
  12. Sands M, Kron MA, Brown RB (1985) Pentamidine: A Review Rev Infect. Dis 7 No 5: 625–634CrossRefGoogle Scholar
  13. Sattler FR, Cowan R, Nielson DM, Ruskin J (1988 a) Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 109: 280–287PubMedGoogle Scholar
  14. Sattler F, Allegra C, Tuazon CA et al. (1988b) Trimetrexate and leucovorin for Pneumocystis carinii pneumonia. (4th International Congress on Aids, Stockholm, abstr)Google Scholar
  15. Skörde J, Heise W, Arasteh K, Mostertz P, L’Age (im Druck) Adjuvante Corticoid-Therapie bei HTV-assoziierter schwerer Pneumocystis carinii-Pneumonie. Update: Acquired immunodeficiency syndrome (Aids-United States) (1986) MMWR 35:17–21Google Scholar
  16. Vega C, Phaneur D, Morisset R (1988) Clindamycin with primaquin for P. carinii pneumonia in Aids. (28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, October, abstr)Google Scholar
  17. Wächter RM, Luced JM, Turner J, Volberding P, Hopwell PC (1986) Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis 134: 891–896PubMedGoogle Scholar
  18. Wharton JM, Coleman DL, Wofsy CB et al. (1986) Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med 195: 37–44Google Scholar
  19. Wofsy CB (1987) Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome. Rev Infect Dis [Suppl 2] 9 184–191CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • M. L’age
  • S. Skörde
  • K. Arasteh
  • W. Heise
  • P. Mostertz
  • K. Nehm

There are no affiliations available

Personalised recommendations